Berith O. Nilsson
Uppsala, C, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Safe engineering of CAR T cells for adoptive cell therapy of cancer using long-term episomal gene transfer.
Journal: EMBO molecular medicine
Published: May 18, 2016
Combining CAR T cells and the Bcl-2 family apoptosis inhibitor ABT-737 for treating B-cell malignancy.
Journal: Cancer gene therapy
Published: May 04, 2013
T cells engineered with a T cell receptor against the prostate antigen TARP specifically kill HLA-A2+ prostate and breast cancer cells.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: September 29, 2012
Adenovirus serotype 5 vectors with Tat-PTD modified hexon and serotype 35 fiber show greatly enhanced transduction capacity of primary cell cultures.
Journal: PloS one
Published: August 01, 2012
The inverted CD4/CD8 ratio and associated parameters in 66-year-old individuals: the Swedish HEXA immune study.
Journal: Age (Dordrecht, Netherlands)
Published: December 21, 2011
CAR/FoxP3-engineered T regulatory cells target the CNS and suppress EAE upon intranasal delivery.
Journal: Journal of neuroinflammation
Published: December 19, 2011
Adenovirus with hexon Tat-protein transduction domain modification exhibits increased therapeutic effect in experimental neuroblastoma and neuroendocrine tumors.
Journal: Journal of virology
Published: September 30, 2011
Showing 1-8 of 8
Last Updated: 09/26/2026